Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
Open Access
- 25 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explained by abnormal loading conditions. Despite its rare prevalence in pediatric age, HCM carries a relevant risk of mortality and morbidity in both infants and children. Pediatric HCM is a large heterogeneous group of disorders. Other than mutations in sarcomeric genes, which represent the most important cause of HCM in adults, childhood HCM includes a high prevalence of non-sarcomeric causes, including inherited errors of metabolism (i.e., glycogen storage diseases, lysosomal storage diseases, and fatty acid oxidation disorders), malformation syndromes, neuromuscular diseases, and mitochondrial disease, which globally represent up to 35% of children with HCM. The age of presentation and the underlying etiology significantly impact the prognosis of children with HCM. Moreover, in recent years, different targeted approaches for non-sarcomeric etiologies of HCM have emerged. Therefore, the etiological diagnosis is a fundamental step in designing specific management and therapy in these subjects. The present review aims to provide an overview of the non-sarcomeric causes of HCM in children, focusing on the pathophysiology, clinical features, diagnosis, and treatment of these rare disorders.Keywords
This publication has 161 references indexed in Scilit:
- Pediatric Cardiomyopathy: Importance of Genetic and Metabolic EvaluationJournal of Cardiac Failure, 2012
- Consensus treatment recommendations for late‐onset Pompe diseaseMuscle & Nerve, 2011
- Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and managementJournal of Inherited Metabolic Disease, 2011
- PTPN11-Associated Mutations in the Heart: Has LEOPARD Changed Its RASpots?Trends in Cardiovascular Medicine, 2011
- Noonan syndrome and clinically related disordersBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Functional performance and muscle strength phenotypes in men and women with Danon diseaseMuscle & Nerve, 2010
- Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like PhenotypeAmerican Journal of Human Genetics, 2010
- A restricted spectrum of NRAS mutations causes Noonan syndromeNature Genetics, 2009
- Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hairNature Genetics, 2009
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndromeNature Genetics, 2006